The amyloid precursor protein APP plays a key role in the pathogenesis of Alzheimer’s disease (AD), as proteolytical cleavage of APP gives rise to the Aß peptide which is deposited in the brains of Alzheimer patients. Despite this, our knowledge of the normal cell biological and physiological functions of APP and the closely related APLPs is limited. This may have hampered our understanding of AD, since evidence has accumulated that not only the production of the Aß peptide but also the loss of APP-mediated functions may contribute to AD pathogenesis. Thus, it appears timely and highly relevant to elucidate the functions of the APP gene family from the molecular level to their role in the intact organism, i.e. in the context of nervous syst...
Increasing evidence suggests that synaptic functions of the amyloid precursor protein (APP), which i...
Increasing evidence suggests that synaptic functions of the amyloid precursor protein (APP), which i...
Alzheimer's disease (AD) is the most common form of dementia affecting 47 million people worldwide a...
The amyloid precursor protein (APP) is well known to be involved in the pathophysiology of Alzheimer...
The Amyloid Precursor Protein (APP) is infamous for its proposed pivotal role in the pathogenesis of...
One of the major neuropathological hallmarks of Alzheimer's disease is the presence of senile plaque...
The pathological implication of amyloid precursor protein (APP) in Alzheimer's disease has been wide...
The pathological implication of amyloid precursor protein (APP) in Alzheimer's disease has been wide...
Alzheimer’s disease is a chronic neurodegenerative disease that causes problems with memory, thinkin...
Alzheimer’s disease (AD) is a neurodegenerative disorder which is histopathologically characterised ...
Beta-amyloid precursor protein (APP) is a membrane-spanning protein with a large extracellular domai...
The amyloid precursor protein (APP) is a type I trans-membrane protein that is expressed in a wide n...
Abstract The amyloid precursor protein (APP) plays a central role in the pathophysiology of Alzheime...
Increasing evidence suggests that synaptic functions of the amyloid precursor protein (APP), which i...
Copyright © 2013 Leland Pung et al. This is an open access article distributed under the Creative Co...
Increasing evidence suggests that synaptic functions of the amyloid precursor protein (APP), which i...
Increasing evidence suggests that synaptic functions of the amyloid precursor protein (APP), which i...
Alzheimer's disease (AD) is the most common form of dementia affecting 47 million people worldwide a...
The amyloid precursor protein (APP) is well known to be involved in the pathophysiology of Alzheimer...
The Amyloid Precursor Protein (APP) is infamous for its proposed pivotal role in the pathogenesis of...
One of the major neuropathological hallmarks of Alzheimer's disease is the presence of senile plaque...
The pathological implication of amyloid precursor protein (APP) in Alzheimer's disease has been wide...
The pathological implication of amyloid precursor protein (APP) in Alzheimer's disease has been wide...
Alzheimer’s disease is a chronic neurodegenerative disease that causes problems with memory, thinkin...
Alzheimer’s disease (AD) is a neurodegenerative disorder which is histopathologically characterised ...
Beta-amyloid precursor protein (APP) is a membrane-spanning protein with a large extracellular domai...
The amyloid precursor protein (APP) is a type I trans-membrane protein that is expressed in a wide n...
Abstract The amyloid precursor protein (APP) plays a central role in the pathophysiology of Alzheime...
Increasing evidence suggests that synaptic functions of the amyloid precursor protein (APP), which i...
Copyright © 2013 Leland Pung et al. This is an open access article distributed under the Creative Co...
Increasing evidence suggests that synaptic functions of the amyloid precursor protein (APP), which i...
Increasing evidence suggests that synaptic functions of the amyloid precursor protein (APP), which i...
Alzheimer's disease (AD) is the most common form of dementia affecting 47 million people worldwide a...